A study which evaluated the serum of 90 patients with RF and of 42 patients with APS, showed that 24% of patients with rheumatic heart disease had positivity for anti-β2GPI and that patients with APS had anti-streptococcal activity, recognizing the M protein in 16.6% of cases. This evidence concerns the gene APOH and autoimmune polyendocrinopathy.